Furiex Pharmaceuticals (NASDAQ:FURX) will report earnings after markets close on Tuesday, May 7th. Furiex Pharmaceuticals Inc. is a drug development company. The company partners with pharmaceutical and biotechnology companies and has a diversified product portfolio and pipeline with multiple therapeutic candidates including late-stage assets and a product on the market.
Here is your Cheat Sheet to Furiex Pharmaceuticals Earnings:
Earnings Expectations: Analysts expect earnings of $0.79 per share on revenues of $33.42 million.
Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $1.07 to a loss $1.14. For the current year, the average estimate is a loss of $1.63, which is better than the estimate ninety days ago.
Here’s how Furiex Pharmaceuticals has been performing on an annual basis:
|Revenue ($) in millions||6.31||8.98||4.49||40.51|
|Diluted EPS ($)||-0.90||-5.53||-4.96||-4.29|
Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:
|Quarter||Dec. 31, 2011||Mar. 31, 2012||Jun. 30, 2012||Sep. 30, 2012||Dec. 31, 2012|
|Revenue ($) in millions||1.99||2.65||13.08||15.58||9.21|
|Diluted EPS ($)||-0.6794||-0.98||-2.09||-0.33||-0.9039|
Furiex Pharmaceuticals has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.
“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)